📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Development of a low-seroprevalence, avß6 integrin-selective virotherapy based on human adenovirus type 10. (2022)

First Author: Bates EA
Attributed to:  MICA: Targeting the Wnt Receptor Frizzled-7 for the Treatment of Gastric Cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omto.2022.03.007

PubMed Identifier: 35399606

Publication URI: http://europepmc.org/abstract/MED/35399606

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecular therapy oncolytics

ISSN: 2372-7705